Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$NRIX Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $4.73 up 559.22% YoY • Reported revenue of $673.06M up 8430.54% YoY • Nurix expects existing cash, cash equivalents and marketable securities of $1.1B to fund operations, including clinical trials and infrastructure, for at least the next 12 months; additional funding will be needed.

Price since post

Full Details

Advertisement|Remove ads.